Bob Lederer RBDR

Disk Jockey Countersues Nielsen over Radio Ratings | RBDR

August 23, 2017. Today on RBDR:

1) Nielsen sued Tampa disc jockey Bubba the Love Sponge for tampering with its local radio ratings service. Bubba countersued and now is attempting to make a case on his behalf using Nielsen’s own radio research data.

2) What causes an American user of apps to delete them – and why a researcher should care?

3) Corporate data is critical in strategic decisions, but some statistics lead one to wonder how much.

RBDR is sponsored this week by RFL Client Consulting, the new service designed to enhance and improve the standing of client research/insights as well as research agencies. Using experiences and the expertise collected from over 300 client research and 1,000 research agency organizations over 23-plus years, RFL Client Consulting is ready to boost their effectiveness and efficiency.

For details on how RFL Client Consulting can help, please click here.

No need to spend time “searching” for today’s RBDR video. Subscribe to receive a FREE, personal email as soon as the new RBDR is uploaded. Click here.

Bob Lederer RBDR

BIGGEST mistakes clients make contracting their MR. (RBDR 10.20.2015)

Today on RBDR:

30 so-called market research experts share on Zintro.com what each believes is the #1 biggest mistake companies make when they contract out market research. (Link to this report HERE.)

RBDR is sponsored by Socratic Technologies, whose proprietary tools and methodologies tackle marketing complexities so that you can make more confident business decisions. Visit their website at sotech.com.

Don’t spend your time “searching” for today’s RBDR video. Subscribe to receive a personal email as soon as the new RBDR is uploaded. Click HERE.

Bob Lederer RFL Communications, Inc.

Big Share draws mktg & finance together; How CMOs should change (RBDR–7/22/14)

RBDR is sponsored this week by Research Now, with the industry’s most comprehensive mobile research platform, ideally suited for custom qualitative and quantitative research.

Mobile is Now. If you would like to find out how to make your surveys mobile-ready, we recommend you register for the complimentary Tuesday August 5 Research Now webinar at http://www.mobilenowsurveys.com.

Making news on RBDR today: 1) MarketShare co-founder and CEO Wes Nichols notes four prominent U.S. corporations who prove his contention that sharing Big Data is driving marketing and finance departments together. 2) A Vivaldi Partners Group study of 50 CMOS on three continents concludes that the Chief Marketing Officer role needs to back off and allow talented individuals working in departments underneath them to play their trade and exert their expert influence.

Bob Lederer RFL Communications, Inc.

Comparing Observational MR; Proposed Part D changes; FDA generic Rx initiative; HIMSS reports on HC mobile implementation vs. usage; MDLinx verifying European MDs; Novartis expands clinical data transparency; SAP testing “Medical Insights” cancer patient assistance (PMRVR–3/4/14)

In this Pharma Market Research VIDEO Report:  1) GRACE, an 11-item checklist of data and methods, allows testing of baseline quality criteria for observational research.  2) The CMS is proposing changes to Medicare Part D. The big picture change calls for stopping automatic Medicare coverage of two drug classes; the underlying consideration in the plan could lead to federal government price negotiations with pharmacos (expressly forbidden in legislation that established Part D).  3) The FDA launches a $20 million initiative to test generic drug production, which represents 80% of Rx drugs. India, wiht its $15 billion in annual generic drug production, is a primary focus but China is also in the crosshairs. 4) HIMSS mobile research study investigates its implementation and use by healthcare providers.  5) GfK reports an upsurge in 2013 in purchase of mobile-connected medical devices in top European countries.  6) MDLinx is launching its physician verification service in Europe.  7) The Kaiser Family Foundation reports users of the ACA website were more price-oriented than physician-focused.  8) Novartis says it has extended its pharmaco leadership in clinical trial data transparency.  9) SAP is testing “Medical Insights,” a capability that aids cancer patients by pulling relevant data from many cancer data sources, runs advanced analytics and delivers customized results in real time.